Form 8-K - Current report:
SEC Accession No. 0001641172-25-019663
Filing Date
2025-07-15
Accepted
2025-07-15 12:32:55
Documents
12
Period of Report
2025-07-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 38243
  Complete submission text file 0001641172-25-019663.txt   204243

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE pcsa-20250715.xsd EX-101.SCH 3059
3 XBRL LABEL FILE pcsa-20250715_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE pcsa-20250715_pre.xml EX-101.PRE 22388
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3697
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 251123955
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)